2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Kwon TK and Kim JC In vitro skin permeation of monoolein nanoparticles containing hydroxypropyl beta-cyclodextrin/minoxidil complex. 2010 Int J Pharm pmid:20362653
Mulet X et al. High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles. 2010 Int J Pharm pmid:20580796
Gan L et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. 2010 Int J Pharm pmid:20558263
Boyd BJ et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. 2007 Int J Pharm pmid:17467935
Phan S et al. Evaluating the link between self-assembled mesophase structure and drug release. 2011 Int J Pharm pmid:21963475
Shah MH et al. Spray dried glyceryl monooleate-magnesium trisilicate dry powder as cubic phase precursor. 2006 Int J Pharm pmid:16846704
Ferreira DA et al. Cryo-TEM investigation of phase behaviour and aggregate structure in dilute dispersions of monoolein and oleic acid. 2006 Int J Pharm pmid:16439076
Pepe D et al. Decylglucoside-based microemulsions for cutaneous localization of lycopene and ascorbic acid. 2012 Int J Pharm pmid:22692080
Réeff J et al. Characterization and optimization of GMO-based gels with long term release for intraarticular administration. 2013 Int J Pharm pmid:23651644
Dash AK et al. Development of a rectal nicotine delivery system for the treatment of ulcerative colitis. 1999 Int J Pharm pmid:10528093
Gonçalves VSS et al. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs. 2016 Int J Pharm pmid:27702697
Shi C et al. Exploring the effect of hydrophilic and hydrophobic structure of grafted polymeric micelles on drug loading. 2016 Int J Pharm pmid:27576669
Sadhale Y and Shah JC Stabilization of insulin against agitation-induced aggregation by the GMO cubic phase gel. 1999 Int J Pharm pmid:10556740
Sadhale Y and Shah JC Biological activity of insulin in GMO gels and the effect of agitation. 1999 Int J Pharm pmid:10556741
Lee J and Kellaway IW Combined effect of oleic acid and polyethylene glycol 200 on buccal permeation of [D-ala2, D-leu5]enkephalin from a cubic phase of glyceryl monooleate. 2000 Int J Pharm pmid:11011997
Réeff J et al. Development and evaluation in vitro and in vivo of injectable hydrolipidic gels with sustained-release properties for the management of articular pathologies such as osteoarthritis. 2015 Int J Pharm pmid:25934426
Sintov AC Transdermal delivery of curcumin via microemulsion. 2015 Int J Pharm pmid:25655717
Zhang Y et al. Transdermal baicalin delivery using diethylene glycol monoethyl ether-mediated cubic phase gel. 2015 Int J Pharm pmid:25543112
Milak S and Zimmer A Glycerol monooleate liquid crystalline phases used in drug delivery systems. 2015 Int J Pharm pmid:25479099
Liu Y et al. Preparation and evaluation of glyceryl monooleate-coated hollow-bioadhesive microspheres for gastroretentive drug delivery. 2011 Int J Pharm pmid:21540088